{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:14:30Z","timestamp":1762607670289,"version":"3.41.2"},"reference-count":19,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Clinically evident cardiac involvement has been documented in 5% of sarcoidosis patients, primarily manifesting as heart block, ventricular arrhythmias, and heart failure. Heart Rhythm Society consensus guidelines recommend advanced cardiac imaging with fluorodeoxyglucose\u2013positron emission tomography (FDG-PET) scan for diagnosis of cardiac sarcoidosis, given endomyocardial biopsy\u2019s low sensitivity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary\u2003<\/jats:title>\n                  <jats:p>We describe four patients with cardiac sarcoidosis diagnosed with FDG-PET scan performed using a standardized imaging protocol for cardiac sarcoidosis. Serial FDG-PET scans were performed to monitor disease progression and response to therapy. Patients 1 and 2 presented with heart block, Patient 3 with heart failure and ventricular tachycardia (VT), and Patient 4 with VT. Patient 1 showed an initial decrease in standard uptake value (SUV) on immunosuppression, followed by an increase in SUV, necessitating steroid therapy. Patient 2\u2019s SUV decreased on immunosuppression. Patient 3 required 3.5\u2009years of immunosuppression for the SUV to decrease to inactive disease levels, with SUV increasing and decreasing at different times during treatment, and subsequently developed VT. For Patient 4, areas of inflammation on the initial scan matched low voltage areas on the patient\u2019s EP study, confirming the arrhythmia\u2019s pathophysiological basis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion\u2003<\/jats:title>\n                  <jats:p>Cardiac sarcoidosis progression and response to therapy are heterogeneous. Serial FDG-PET scans are useful to diagnose disease, tailor therapy, and monitor the clinical course of disease, allowing treatment decisions to be based on the quantitative level of inflammation seen on FDG-PET.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytz188","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T18:58:05Z","timestamp":1572461885000},"source":"Crossref","is-referenced-by-count":2,"title":["The use of serial cardiac 18F-fluorodeoxyglucose\u2013 positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and review"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8180-1886","authenticated-orcid":false,"given":"Cooper B","family":"Kersey","sequence":"first","affiliation":[{"name":"University of Washington School of Medicine, Department of Medicine, 1959 NE Pacific St, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen R","family":"Flaherty","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, Irving Medical Center, Columbia University, 622 W 168th St, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-8786","authenticated-orcid":false,"given":"Isaac L","family":"Goldenthal","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, Irving Medical Center, Columbia University, 622 W 168th St, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Bokhari","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, Irving Medical Center, Columbia University, 622 W 168th St, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo B","family":"Biviano","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine, Irving Medical Center, Columbia University, 622 W 168th St, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"2019103013405152400_ytz188-B1","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2019103013405152400_ytz188-B2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/17476348.2018.1511431","article-title":"Cardiac sarcoidosis\u2014an expert review for the chest physician","volume":"13","author":"Ho","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"2019103013405152400_ytz188-B3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/hrt.36.1.54","article-title":"Sarcoid heart disease","volume":"36","author":"Fleming","year":"1974","journal-title":"Br Heart J"},{"key":"2019103013405152400_ytz188-B4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"2019103013405152400_ytz188-B5","doi-asserted-by":"crossref","first-page":"1386.","DOI":"10.1002\/clc.23060","article-title":"Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: proposed modification of current guidelines","volume":"41","author":"Sohn","year":"2018","journal-title":"Clin Cardiol"},{"key":"2019103013405152400_ytz188-B6","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"key":"2019103013405152400_ytz188-B7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"2019103013405152400_ytz188-B8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.hrcr.2018.04.005","article-title":"Syncope on exertion in a young male","volume":"4","author":"Erath","year":"2018","journal-title":"HeartRhythm Case Rep"},{"key":"2019103013405152400_ytz188-B9","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1148\/rg.2018180053","article-title":"PET\/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations","volume":"38","author":"Akaike","year":"2018","journal-title":"Radiographics"},{"key":"2019103013405152400_ytz188-B10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC Expert Consensus Document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"2019103013405152400_ytz188-B11","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"year":"2017","author":"Bokhari","key":"2019103013405152400_ytz188-B12"},{"key":"2019103013405152400_ytz188-B13","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1155\/2013\/623036","article-title":"The use of 18F-FDG-PET\/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases","volume":"2013","author":"Glaudemans","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2019103013405152400_ytz188-B14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2019103013405152400_ytz188-B15","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"2019103013405152400_ytz188-B16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2019103013405152400_ytz188-B17","first-page":"288","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"26","author":"Flores","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2019103013405152400_ytz188-B18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2019103013405152400_ytz188-B19","article-title":"Role of PET\/CT in multimodality imaging in differentiating cardiac sarcoidosis from arrhythmogenic right ventricular dysplasia","author":"Goh","year":"2018","journal-title":"J Nucl Cardiol"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytz188\/30333999\/ytz188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytz188\/30333999\/ytz188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T18:58:11Z","timestamp":1572461891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article\/doi\/10.1093\/ehjcr\/ytz188\/5610126"}},"subtitle":[],"editor":[{"given":"Riccardo","family":"Liga","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Joseph","family":"Moutiris","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Liga","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Rahul","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Peregrine","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytz188","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"article-number":"ytz188"}}